Azurity Pharmaceuticals, Inc. vs. EXELIXIS, INC.
Explore the PTAB proceeding IPR2025-00427 filed by Azurity Pharmaceuticals, Inc. on 2025-01-09. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2025-00427
Filing Date
2025-01-09
Accorded Filing Date
2025-01-09
Institution Decision Date
2025-07-02
Last Modified Date
2025-10-06
Proceeding Type
IPR
Termination Date
2025-07-02
Trial Status
Discretionary Denial
Parties & Counsel
Petitioner
Azurity Pharmaceuticals, Inc.
Represented By
Morrell, Andrewet alPatent Owner / Respondent
EXELIXIS, INC.
Represented By
Whelan, Emilyet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Discretionary Denial
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 31060 | Pamela Simonton | +1 650-344-9441 |
| 34251 | Douglas Siegel | +1 616-649-1920 |
| 34440 | Eric Sosenko | +1 734-418-4252 |
| 35004 | Thomas Wootton | +1 269-337-7706 |
| 40259 | Lucy Yang | +1 269-337-7746 |
| 48951 | Heidi Berven | +1 269-337-7710 |
| 49048 | Timothy Bogel | +1 248-566-8526 |
| 50852 | Jonathan O'Brien | +1 269-337-7704 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 14 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 12,128,039 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2025001791 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2025026220 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2026019185 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2011614415 | US Continuation / Sibling | View Official Patent → |
| ๐ PCT International (WIPO) | WO 2012109510 A1 | PCT World Application | View Official Patent → |
| ๐บ๐ธ United States | US 2014139845 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,123,999 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,543,206 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2020010805 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2021015418 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,298,349 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2022017575 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2023184627 | US Continuation / Sibling | View Official Patent → |
Azurity Pharmaceuticals, Inc. v. EXELIXIS, INC.